Company intelligence / Profile preview

Aeras Global Vaccine Foundation

Rockville, Maryland, United Statesaeras.org ↗
Ownership
Private
Employees
~120
Development stage
Other
01

Overview

Aeras Global Vaccine Foundation (Aeras) was a non-profit product development partnership (PDP) dedicated to developing new, effective vaccines against tuberculosis (TB). Founded in 2003 and headquartered in Rockville, Maryland, Aeras collaborated with global biotech, pharmaceutical, and academic partners to advance a diverse pipeline of TB vaccine candidates. The organization was primarily funded by the Bill & Melinda Gates Foundation, the UK Department for International Development (DFID), and other global health donors. In 2015, Aeras sold its biopharmaceutical manufacturing facility to IDT Biologika, and in October 2018, it transferred its remaining clinical research programs, assets, and staff to the International AIDS Vaccine Initiative (IAVI), ending its independent operations.

Therapeutic areas
Infectious Diseases
Modalities
VaccineBiologicRecombinant proteinLive biotherapeutic product therapyGene therapy
Industry
Biotech
02

Drug pipeline

2 assets

H4:IC31

2

1 more asset in the full pipeline.

03

Partnerships

GSKCrucellStatens Serum InstitutInternational AIDS Vaccine InitiativeBill & Melinda Gates Medical Research InstituteIDRIBiofabri

Beyond the preview

Go deeper on Aeras Global Vaccine Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aeras Global Vaccine Foundation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call